Showing 2971-2980 of 4165 results for "".
- ExoCoBio Obtains GMP Licenses for Exosome Biopharmaceuticals in Korea and Hyaluronic Acid (HA) Dermal Fillers in Brazilhttps://modernaesthetics.com/news/exocobio-obtains-gmp-licenses-for-exosome-biopharmaceuticals-in-korea-and-hyaluronic-acid-ha-dermal-fillers-in-brazil/2473370/ExoCoBio announced that it has obtained the "Certificate of Advanced Biopharmaceutical Manufacturing" from the Ministry of Food and Drug Safety in Korea, and the "HA Filler GMP Certification" from the Brazilian Food and Drug Health Monitoring Agency (ANVISA). Accordi
- Collab Alert: Dior Beauty and Hydrafacial Introduce the Dior Powered by Hydrafacialhttps://modernaesthetics.com/news/collab-alert-dior-beauty-and-hydrafacial-introduce-the-dior-powered-by-hydrafacial/2473365/Dior Beauty is joining forces with The BeautyHealth Company for a custom Dior powered by Hydrafacial experience which will be available exclusively at Dior spas from April 2023. The Dior powered by Hydrafacial experience debuts a custom protocol co-created by Hydrafa
- CoolHealth Rolls Out TargetCool for Post-Procedure Pain Controlhttps://modernaesthetics.com/news/coolhealth-rolls-out-targetcool-for-post-procedure-pain-controlmo/2473359/CoolHealth is entering the U.S. market with TargetCool. Leveraging tuneable cooling technology, TargetCool rapidly cools the skin, allowing providers to specifically set a “target” skin temperature down to the exact degree and secon
- Rewards Program Launched for High-Volume AviClear Usershttps://modernaesthetics.com/news/rewards-program-launched-for-high-volume-aviclear-users/2473358/Practices in the United States and Canada using AviClear will now have access to more perks. Cutera announced that it will be launching a rewards program for AviClear practices designed to reinforce a partnership approach with practices with improved profitability, e
- Game Change: Galderma Launches FACE by Galdermahttps://modernaesthetics.com/news/galderma-launches-face-by-galderma/2473349/Galderma is launching FACE by Galderma, an app that simulates the results of injectable treatments in real time using digital facial assessment. The technology was unveiled at the International Master Course on Aging Science (IMCAS) World Congress 2023 in Paris. FACE by Galder
- Juvederm Volux XC for Jaw Definition Is Herehttps://modernaesthetics.com/news/juvederm-volux-xc-for-jaw-definition-is-here/2473344/Allergan Aesthetics' Juvéderm Volux XC is now available at aesthetic practices nationwide. The filler is approved for patients older than 21 with moderate to severe loss of jawline definition. "With 40% of aesthetically-aware consumers considering tre
- Endo Pulls Qwo from Markethttps://modernaesthetics.com/news/endo-pulls-qwo-from-market/2473339/Endo International plc is ceasing the production and sale of Endo Aesthetics' Qwo (collagenase clostridium histolyticum-aaes) in light of market concerns about the extent and variability of bruising following initial treatment as well as the potential for prolonged skin discoloratio
- Cosmetic Physician Partners Launches Network of Physician-led Medical Aesthetics Clinics in UShttps://modernaesthetics.com/news/cosmetic-physician-partners-launches-network-of-physician-led-medical-aesthetics-clinics-in-us/2473334/Cosmetic Physician Partners Inc. ("CPP") is pleased to announce its official launch in the US with the closing of its 10th medical aesthetics clinic. Led by Dr. A. Jay Burns, Dr. Joel L. Cohen, Matt and Kathy Taranto and Dan Schacter, CPP is a partnership designed to provide physician o
- Teyana Taylor Tapped as New Xeomin Brand Partnerhttps://modernaesthetics.com/news/teyana-taylor-tapped-as-new-xeomin-brand-partner/2473321/Xeomin, an FDA-approved double filtered anti-wrinkle injection to temporarily improve the appearance of frown lines with only the ingredients that work and none that don’t. “I always strive to understand the ingredients in any product I’m using and listen to trusted so
- Hugel Resubmits BLA for Botulaxhttps://modernaesthetics.com/news/hugel-resubmits-bla-for-botulax/2473314/Hugel resubmitted the BLA for its botulinum toxin called Botulax for smoothing glabellar lines to the U.S. FDA. Hugel had received a Complete Response Letter (CRL) from the U.S. FDA last March after submitting the BLA for Botulax (50 and 100 units) to advance into the U.S. market i